DEA CME Requirements & Resources
On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance-use disorders.
This reference page is a resource for members to assist them in meeting these requirements. The Substance Abuse and Mental Health Services Administration (SAMHSA), recommends that content should be related to the prevention, recognition, and care of people with substance-use disorders including those with concurrent pain and/or psychiatric and medical comorbidities.
While we are not able to definitively interpret the rule language to determine which specific programs meet this requirement, we are providing a list of our recent CME activities as well as additional resources to assist you in meeting this requirement.
Starting on June 27, 2023, when physicians renew (or submit their initial) DEA registration, they will be required to attest that they have completed 8 hours of education in the treatment and management of patients with opioid or other substance use disorders.
This is a one-time requirement and can include previous CME programs that you have completed (with no apparent requirement for the education to be recently obtained - there is no limit to how far back the education could have been completed).
Exemptions:
Resources:
Total Credits: 1 including 1 AOA Category 1-A Credit(s), 1 Opioid Credits
Total Credits: .75 including .75 AOA Category 1-A Credit(s), .75 AMA PRA Category 1 Credit(s)™
Total Credits: 8 including 8 AOA Category 1-A Credit(s)
Total Credits: 1 including 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™
Total Credits: 1 including 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™
Total Credits: 1 including 1 AOA Category 1-A Credit(s)